Literature DB >> 19842879

Extreme variant of enlarged heterochromatin region on chromosome 9Q in a normal child and multiple family members.

Thora S Steffensen1, Enid Gilbert-Barness, Mary Sandstrom, John R Bell, Jenny Bryan, Maxine J Sutcliffe.   

Abstract

Heteromorphisms of chromosome 9 are among the most common variations in the human karyotype. The pericentromeric polymorphisms of chromosome 9 include variations in the size of q-arm heterochromatin, pericentric inversions, and rarely, additional C-band-negative, G-band-positive material. The finding of a polymorphic variant, either in prenatal screening or in chromosomal analysis for phenotypic abnormalities, may cause parental anxiety and initiate genetic counselling. We report a case of a 39-year-old primigravida with unremarkable pregnancy, who had amniocentesis due to advanced maternal age. Chromosomal analysis demonstrated a long arm (q) variant of chromosome 9 with an enlarged heteromorphic area, approximately three times longer than known reported variants. Prenatal analysis demonstated an identical variant in the probands phenotypically normal father, uncle, and paternal grandmother, confirming an apparently "normal" variant.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19842879     DOI: 10.1080/15513810903203180

Source DB:  PubMed          Journal:  Fetal Pediatr Pathol        ISSN: 1551-3815            Impact factor:   0.958


  1 in total

1.  Heteromorphic variants of chromosome 9.

Authors:  Nadezda Kosyakova; Ani Grigorian; Thomas Liehr; Marina Manvelyan; Isabella Simonyan; Hasmik Mkrtchyan; Rouben Aroutiounian; Anna D Polityko; Anna I Kulpanovich; Tatiana Egorova; Evgenia Jaroshevich; Alla Frolova; Natalia Shorokh; Irina V Naumchik; Marianne Volleth; Isolde Schreyer; Heike Nelle; Markus Stumm; Rolf-Dieter Wegner; Gisela Reising-Ackermann; Martina Merkas; Lukretija Brecevic; Thomas Martin; Laura Rodríguez; Samarth Bhatt; Monika Ziegler; Katharina Kreskowski; Anja Weise; Ali Sazci; Svetlana Vorsanova; Marcelo de Bello Cioffi; Emel Ergul
Journal:  Mol Cytogenet       Date:  2013-04-01       Impact factor: 2.009

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.